Tandem DBS for Parkinson's Disease: A Pilot Study Utilizing STN/GPi + Hypothalamic Stimulation



Status:Enrolling by invitation
Conditions:Parkinsons Disease, Psychiatric
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:40 - 80
Updated:4/17/2018
Start Date:April 2012
End Date:January 2025

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria
Does dual hemispheric stimulation of the subthalamic nucleus (STN) and fornix/hypothalamus
potentially improve cognitive function in patients with Parkinsons disease.


Inclusion Criteria:

- All patients will be enrolled from the practice of the primary investigator.

- Parkinson's Disease (PD) patients in whom optimal medical therapy has failed.

- All patients will have responsivity to levodopa.

- Individuals with normal or mild cognitive impairment.

Exclusion Criteria:

- Clinically significant dementia

- Other significant neurological or psychiatric disease

- Previous brain surgery including pallidotomy or thalamotomy

- Previous placement of other implantable devices
We found this trial at
1
site
Mayo Clinic Florida
4500 San Pablo Rd S
Jacksonville, Florida 32224
(904) 953-2000
Mayo Clinic Florida Thousands of people come to Mayo Clinic in Jacksonville, Fla., annually for...
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials